Clinical Trials for Pediatric Sarcomas

3 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TherapeuticVICCSAR1169
08/03/2012
A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
TherapeuticCOGADVL1121
06/13/2012
ADVL1121 - A Phase II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (IND# 69896) in Children and Young Adults With Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, and Papillary Thyroid Carcinoma
CorrelativeVICCSAR1275
03/21/2013
Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma

You do not have JavaScript enabled. This site works better with JavaScript turned on.